[1] |
ASRANI SK, SIMONETTO DA, KAMATH PS. Acute-on-chronic liver failure[J]. Clin Gastroenterol Hepatol, 2015, 13( 12): 2128- 2139. DOI: 10.1016/j.cgh.2015.07.008.
|
[2] |
REVERTER E, TANDON P, AUGUSTIN S, et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding[J]. Gastroenterology, 2014, 146( 2): 412- 419.e 3. DOI: 10.1053/j.gastro.2013.10.018.
|
[3] |
ARTRU F, LOUVET A, RUIZ I, et al. Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3[J]. J Hepatol, 2017, 67( 4): 708- 715. DOI: 10.1016/j.jhep.2017.06.009.
|
[4] |
SARIN SK, CHOUDHURY A, SHARMA MK, et al. Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific association for the study of the liver(APASL): An update[J]. Hepatol Int, 2019, 13( 4): 353- 390. DOI: 10.1007/s12072-019-09946-3.
|
[5] |
CHOUDHURY A, JINDAL A, MAIWALL R, et al. Liver failure determines the outcome in patients of acute-on-chronic liver failure(ACLF): Comparison of APASL ACLF research consortium(AARC) and CLIF-SOFA models[J]. Hepatol Int, 2017, 11( 5): 461- 471. DOI: 10.1007/s12072-017-9816-z.
|
[6] |
MEZZANO G, JUANOLA A, CARDENAS A, et al. Global burden of disease: Acute-on-chronic liver failure, a systematic review and meta-analysis[J]. Gut, 2022, 71( 1): 148- 155. DOI: 10.1136/gutjnl-2020-322161.
|
[7] |
WANG HM, TONG JJ, XU X, et al. Reversibility of acute-on-chronic liver failure syndrome in hepatitis B virus-infected patients with and without prior decompensation[J]. J Viral Hepat, 2022, 29( 10): 890- 898. DOI: 10.1111/jvh.13732.
|
[8] |
LIN X, HUANG X, WANG L, et al. Prognostic value of acute-on-chronic liver failure(ACLF) score in critically ill patients with cirrhosis and ACLF[J]. Med Sci Monit, 2020, 26: e926574. DOI: 10.12659/msm.926574.
|
[9] |
MAIWALL R, PASUPULETI SSR, CHOUDHURY A, et al. AARC score determines outcomes in patients with alcohol-associated hepatitis: A multinational study[J]. Hepatol Int, 2023, 17( 3): 662- 675. DOI: 10.1007/s12072-022-10463-z.
|
[10] |
MOREAU R, JALAN R, GINES P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J]. Gastroenterology, 2013, 144( 7): 1426- 1437, 1437.e1-e 9. DOI: 10.1053/j.gastro.2013.02.042.
|
[11] |
SY E, RONCO JJ, SEARLE R, et al. Prognostication of critically ill patients with acute-on-chronic liver failure using the Chronic Liver Failure-Sequential Organ Failure Assessment: A Canadian retrospective study[J]. J Crit Care, 2016, 36: 234- 239. DOI: 10.1016/j.jcrc.2016.08.003.
|
[12] |
MAIPANG K, POTRANUN P, CHAINUVATI S, et al. Validation of the prognostic models in acute-on-chronic liver failure precipitated by hepatic and extrahepatic insults[J]. PLoS One, 2019, 14( 7): e0219516. DOI: 10.1371/journal.pone.0219516.
|
[13] |
HERNAEZ R, SOLÀ E, MOREAU R, et al. Acute-on-chronic liver failure: An update[J]. Gut, 2017, 66( 3): 541- 553. DOI: 10.1136/gutjnl-2016-312670.
|
[14] |
GUSTOT T, FERNANDEZ J, GARCIA E, et al. Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis[J]. Hepatology, 2015, 62( 1): 243- 252. DOI: 10.1002/hep.27849.
|
[15] |
DHIMAN RK, AGRAWAL S, GUPTA T, et al. Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome[J]. World J Gastroenterol, 2014, 20( 40): 14934- 14941. DOI: 10.3748/wjg.v20.i40.14934.
|
[16] |
MACDONALD S, ANDREOLA F, BACHTIGER P, et al. Cell death markers in patients with cirrhosis and acute decompensation[J]. Hepatology, 2018, 67( 3): 989- 1002. DOI: 10.1002/hep.29581.
|
[17] |
BAJAJ JS, REDDY KR, O’LEARY JG, et al. Serum levels of metabolites produced by intestinal microbes and lipid moieties independently associated with acute-on-chronic liver failure and death in patients with cirrhosis[J]. Gastroenterology, 2020, 159( 5): 1715- 1730.e 12. DOI: 10.1053/j.gastro.2020.07.019.
|
[18] |
CLÀRIA J, STAUBER RE, COENRAAD MJ, et al. Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure[J]. Hepatology, 2016, 64( 4): 1249- 1264. DOI: 10.1002/hep.28740.
|
[19] |
ZACCHERINI G, AGUILAR F, CARACENI P, et al. Assessing the role of amino acids in systemic inflammation and organ failure in patients with ACLF[J]. J Hepatol, 2021, 74( 5): 1117- 1131. DOI: 10.1016/j.jhep.2020.11.035.
|
[20] |
BAJAJ JS, O’LEARY JG, REDDY KR, et al. Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures[J]. Hepatology, 2014, 60( 1): 250- 256. DOI: 10.1002/hep.27077.
|
[21] |
LI F, THULUVATH P. EASL-CLIF criteria perform better than NACSELD to diagnose and prognosticate ACLF[J]. J Hepatol, 2021, 75( 5): 1096- 1103. DOI: 10.1016/j.jhep.2021.05.033.
|
[22] |
CAO ZJ, LIU YH, CAI MH, et al. The use of NACSELD and EASL-CLIF classification systems of ACLF in the prediction of prognosis in hospitalized patients with cirrhosis[J]. Am J Gastroenterol, 2020, 115( 12): 2026- 2035. DOI: 10.14309/ajg.0000000000000771.
|
[23] |
O’LEARY JG, REDDY KR, GARCIA-TSAO G, et al. NACSELD acute-on-chronic liver failure(NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis[J]. Hepatology, 2018, 67( 6): 2367- 2374. DOI: 10.1002/hep.29773.
|
[24] |
WONG F, PIANO S, SINGH V, et al. Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure[J]. J Hepatol, 2021, 74( 2): 330- 339. DOI: 10.1016/j.jhep.2020.07.046.
|
[25] |
ZANETTO A, PELIZZARO F, CAMPELLO E, et al. Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis[J]. J Hepatol, 2023, 78( 2): 301- 311. DOI: 10.1016/j.jhep.2022.09.005.
|
[26] |
BELLI LS, DUVOUX C, ARTZNER T, et al. Liver transplantation for patients with acute-on-chronic liver failure(ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study(ECLIS)[J]. J Hepatol, 2021, 75( 3): 610- 622. DOI: 10.1016/j.jhep.2021.03.030.
|
[27] |
WU TZ, LI J, SHAO L, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure[J]. Gut, 2018, 67( 12): 2181- 2191. DOI: 10.1136/gutjnl-2017-314641.
|
[28] |
TIAN XL, WU SL, WANG B, et al. Value of the COSSH-ACLFs model in predicting the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure[J]. J Clin Hepatol, 2020, 36( 6): 1258- 1262. DOI: 10.3969/j.issn.1001-5256.2020.06.014.
田小利, 吴松林, 王波, 等. COSSH-ACLFs评分模型对HBV相关慢加急性肝衰竭患者短期预后的预测价值[J]. 临床肝胆病杂志, 2020, 36( 6): 1258- 1262. DOI: 10.3969/j.issn.1001-5256.2020.06.014.
|
[29] |
SHEN ZM, CHEN WJ, LIU YC, et al. Predictive value of COSSH-ACLFⅡ score for short-term prognosis in patients with acute-on-chronic liver failure[J]. Chin Hepatol, 2023, 28( 1): 41- 45. DOI: 10.14000/j.cnki.issn.1008-1704.2023.01.029.
沈周明, 陈伟杰, 刘一村, 等. COSSH-ACLFⅡ评分对慢加急性肝衰竭患者短期预后的预测价值[J]. 肝脏, 2023, 28( 1): 41- 45. DOI: 10.14000/j.cnki.issn.1008-1704.2023.01.029.
|
[30] |
LIU WS, SHEN LJ, TIAN H, et al. ABC prognostic classification and MELD 3.0 and COSSH-ACLF Ⅱ prognostic evaluation in acute-on-chronic liver failure[J]. Chin J Hepatol, 2022, 30( 9): 976- 980. DOI: 10.3760/cma.j.cn501113-20220308-00103.
刘婉姝, 申力军, 田华, 等. 慢加急性肝衰竭ABC分型的预后及MELD 3.0和COSSH-ACLF Ⅱ对预后评估[J]. 中华肝脏病杂志, 2022, 30( 9): 976- 980. DOI: 10.3760/cma.j.cn501113-20220308-00103.
|
[31] |
JALAN R, YURDAYDIN C, BAJAJ JS, et al. Toward an improved definition of acute-on-chronic liver failure[J]. Gastroenterology, 2014, 147( 1): 4- 10. DOI: 10.1053/j.gastro.2014.05.005.
|
[32] |
BERNAL W, JALAN R, QUAGLIA A, et al. Acute-on-chronic liver failure[J]. Lancet, 2015, 386( 10003): 1576- 1587. DOI: 10.1016/S0140-6736(15)00309-8.
|
[33] |
Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
|
[34] |
TREBICKA J, FERNANDEZ J, PAPP M, et al. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology[J]. J Hepatol, 2020, 73( 4): 842- 854. DOI: 10.1016/j.jhep.2020.06.013.
|
[35] |
XU MM, KONG M, CAO YY, et al. A new perspective on acute-on-chronic liver failure based on clinical outcome of dynamic classification criteria[J]. Chin J Hepatol, 2020, 28( 4): 319- 325. DOI: 10.3760/cma.j.cn501113-0309-00099.
徐曼曼, 孔明, 曹影影, 等. 慢加急性肝衰竭分型新视点: 基于临床转归的动态分型新标准[J]. 中华肝脏病杂志, 2020, 28( 4): 319- 325. DOI: 10.3760/cma.j.cn501113-0309-00099.
|
[36] |
CHEN Y. Highlight of a new clinical classification of acute-on-chronic liver failure[J]. J Pract Hepatol, 2020, 23( 4): 457- 458. DOI: 10.3969/j.issn.1672-5069.2020.04.001.
陈煜. 再论慢加急性肝衰竭新的临床分型及临床意义[J]. 实用肝脏病杂志, 2020, 23( 4): 457- 458. DOI: 10.3969/j.issn.1672-5069.2020.04.001.
|